Richard Fante has served as Chief Commercial Officer and Head of Business Development for Innocoll, Inc. since August 2015 and as President of RF Consulting LLC since April 11, 2013. Prior to founding RF Consulting, Mr. Fante spent over nineteen years at AstraZeneca pharmaceuticals in the United States. He served in a number of roles, most recently as President US, CEO North America and Regional Vice President of the Americas. Prior to assuming his role as President AstraZeneca US in November 2008, Mr. Fante served as the head of Brand Strategy and Portfolio Operations at AstraZeneca. Before joining AstraZeneca in January 1995, Mr. Fante worked at Lederle Laboratories where he started his career as a sales representative. Mr. Fante served as Board Chairman of the National Pharmaceutical Council (2012) and was a member of the Institute of Medicine of the National Academies of Science Roundtable on Value and Science. Mr. Fante holds a BA in Biology from Princeton University and an MBA from the University of North Carolina Chapel Hill. Mr. Fante’s qualifications to serve on the Board of Directors include his experience as a pharmaceutical executive and his leadership in the development and commercialization of pharmaceutical products including Crestor®, Seroquel®, Nexium®, and Symbicort®.

clinical science